About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rassf5tm1Kina
targeted mutation 1, Tatsuo Kinashi
MGI:3054868
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rassf5tm1Kina/Rassf5tm1Kina B6.Cg-Rassf5tm1Kina MGI:4939894
hm2
Rassf5tm1Kina/Rassf5tm1Kina involves: C57BL/6 * CBA * ICR MGI:3054901
ht3
Rassf5tm1Kina/Rassf5+ involves: C57BL/6 * CBA * ICR MGI:3054902
cx4
Cdkn1btm2Kin/Cdkn1btm2Kin
Rassf5tm1Kina/Rassf5tm1Kina
involves: C57BL/6 * CBA MGI:4939905


Genotype
MGI:4939894
hm1
Allelic
Composition
Rassf5tm1Kina/Rassf5tm1Kina
Genetic
Background
B6.Cg-Rassf5tm1Kina
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rassf5tm1Kina mutation (0 available); any Rassf5 mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• total B and T cells are increased by about 50% (J:168749)
• total B and T cells are increased by about 50% (J:168749)
• CD138+B220+ plasma cells are increased in 10 month old female mutants (J:168749)
• CD138+B220+ plasma cells are increased in 10 month old female mutants (J:168749)
• total B and T cells are increased by about 50% (J:168749)
• total B and T cells are increased by about 50% (J:168749)
• CD44+CD62L- effector-memory T cells are increased in 10 month old female mutants (J:168749)
• CD44+CD62L- effector-memory T cells are increased in 10 month old female mutants (J:168749)
• lymphocyte hyperproliferation, with lymphocytes exhibiting enhanced S phase entry after stimulation (J:168749)
• lymphocyte hyperproliferation, with lymphocytes exhibiting enhanced S phase entry after stimulation (J:168749)
• primary B cells exhibit accelearated S phase entry after stimulation (J:168749)
• primary B cells exhibit accelearated S phase entry after stimulation (J:168749)
• aged mice exhibit a 2-fold increase in serum IgG compared to wild-type mice (J:168749)
• deposits of IgG and C3 in the kidney (J:168749)
• aged mice exhibit a 2-fold increase in serum IgG compared to wild-type mice (J:168749)
• deposits of IgG and C3 in the kidney (J:168749)
• primary T cells exhibit accelerated S phase entry after stimulation (J:168749)
• primary T cells exhibit accelerated S phase entry after stimulation (J:168749)
• aged mice exhibit high titers of antibodies to dsDNA (J:168749)
• aged mice exhibit high titers of antibodies to dsDNA (J:168749)
• females exhibit evidence of glomerulonephritis by 10 months of age while males show similar phenotypes at a later age of 15-18 months (J:168749)
• females exhibit evidence of glomerulonephritis by 10 months of age while males show similar phenotypes at a later age of 15-18 months (J:168749)

tumorigenesis
• mutants develop B220+CD19+ diffuse large B cell lymphomas (J:168749)
• about 30% of mutants develop B cell lymphomas in peripheral lymph nodes and spleen at 1 year of age (J:168749)
• lymphomas are IgM+, IgD+, CD21+, CD23+, and mature B cell type; progressed lymphomas often lose these markers (J:168749)
• lymphomas are monoclonal or oligoclonal in origin (J:168749)
• B cell lymphomas are not related to severity of autoimmune phenotypes (J:168749)
• mutants develop B220+CD19+ diffuse large B cell lymphomas (J:168749)
• about 30% of mutants develop B cell lymphomas in peripheral lymph nodes and spleen at 1 year of age (J:168749)
• lymphomas are IgM+, IgD+, CD21+, CD23+, and mature B cell type; progressed lymphomas often lose these markers (J:168749)
• lymphomas are monoclonal or oligoclonal in origin (J:168749)
• B cell lymphomas are not related to severity of autoimmune phenotypes (J:168749)
• mutants develop lung adenocarcinomas after 1.5 years of age (J:168749)
• mutants develop lung adenocarcinomas after 1.5 years of age (J:168749)
• mutants develop hepatocellular carcinomas after 1.5 years of age (J:168749)
• mutants develop hepatocellular carcinomas after 1.5 years of age (J:168749)

hematopoietic system
• total B and T cells are increased by about 50% (J:168749)
• total B and T cells are increased by about 50% (J:168749)
• CD138+B220+ plasma cells are increased in 10 month old female mutants (J:168749)
• CD138+B220+ plasma cells are increased in 10 month old female mutants (J:168749)
• total B and T cells are increased by about 50% (J:168749)
• total B and T cells are increased by about 50% (J:168749)
• CD44+CD62L- effector-memory T cells are increased in 10 month old female mutants (J:168749)
• CD44+CD62L- effector-memory T cells are increased in 10 month old female mutants (J:168749)
• lymphocyte hyperproliferation, with lymphocytes exhibiting enhanced S phase entry after stimulation (J:168749)
• lymphocyte hyperproliferation, with lymphocytes exhibiting enhanced S phase entry after stimulation (J:168749)
• primary B cells exhibit accelearated S phase entry after stimulation (J:168749)
• primary B cells exhibit accelearated S phase entry after stimulation (J:168749)
• aged mice exhibit a 2-fold increase in serum IgG compared to wild-type mice (J:168749)
• deposits of IgG and C3 in the kidney (J:168749)
• aged mice exhibit a 2-fold increase in serum IgG compared to wild-type mice (J:168749)
• deposits of IgG and C3 in the kidney (J:168749)
• primary T cells exhibit accelerated S phase entry after stimulation (J:168749)
• primary T cells exhibit accelerated S phase entry after stimulation (J:168749)

homeostasis/metabolism

renal/urinary system
• females exhibit evidence of glomerulonephritis by 10 months of age while males show similar phenotypes at a later age of 15-18 months (J:168749)
• females exhibit evidence of glomerulonephritis by 10 months of age while males show similar phenotypes at a later age of 15-18 months (J:168749)

Mouse Models of Human Disease
OMIM ID Ref(s)
Systemic Lupus Erythematosus; SLE 152700 J:168749




Genotype
MGI:3054901
hm2
Allelic
Composition
Rassf5tm1Kina/Rassf5tm1Kina
Genetic
Background
involves: C57BL/6 * CBA * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rassf5tm1Kina mutation (0 available); any Rassf5 mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• defective chemokine-triggered lymphocyte adhesion and migration (J:92670)
• defective chemokine-triggered lymphocyte adhesion and migration (J:92670)
• decrease in double positive CD4+ CD8+ cells (J:92670)
• increase in single positive CD4+ and CD8+ cells (J:92670)
• cellular migration out of thymus is 10% of wildtype (J:92670)
• decrease in double positive CD4+ CD8+ cells (J:92670)
• increase in single positive CD4+ and CD8+ cells (J:92670)
• cellular migration out of thymus is 10% of wildtype (J:92670)
• boundary of cortex and medulla ambiguous (J:92670)
• boundary of cortex and medulla ambiguous (J:92670)
• spotty appearance of medulla (J:92670)
• spotty appearance of medulla (J:92670)
• total thymocyte numbers decreased 50-60% in 7-9 week old mice (J:92670)
• total thymocyte numbers decreased 50-60% in 7-9 week old mice (J:92670)
• impairment of B cell maturation (J:92670)
• defective trafficking of B cells into spleen (J:92670)
• increased number of immature B cells in blood (J:92670)
• impairment of B cell maturation (J:92670)
• defective trafficking of B cells into spleen (J:92670)
• increased number of immature B cells in blood (J:92670)
• reciprocal increase in T and B cells in splenic red pulp (J:92670)
• reciprocal increase in T and B cells in splenic red pulp (J:92670)

immune system
• defective chemokine-triggered lymphocyte adhesion and migration (J:92670)
• defective chemokine-triggered lymphocyte adhesion and migration (J:92670)
• decrease in double positive CD4+ CD8+ cells (J:92670)
• increase in single positive CD4+ and CD8+ cells (J:92670)
• cellular migration out of thymus is 10% of wildtype (J:92670)
• decrease in double positive CD4+ CD8+ cells (J:92670)
• increase in single positive CD4+ and CD8+ cells (J:92670)
• cellular migration out of thymus is 10% of wildtype (J:92670)
• boundary of cortex and medulla ambiguous (J:92670)
• boundary of cortex and medulla ambiguous (J:92670)
• spotty appearance of medulla (J:92670)
• spotty appearance of medulla (J:92670)
• total thymocyte numbers decreased 50-60% in 7-9 week old mice (J:92670)
• total thymocyte numbers decreased 50-60% in 7-9 week old mice (J:92670)
• impairment of B cell maturation (J:92670)
• defective trafficking of B cells into spleen (J:92670)
• increased number of immature B cells in blood (J:92670)
• impairment of B cell maturation (J:92670)
• defective trafficking of B cells into spleen (J:92670)
• increased number of immature B cells in blood (J:92670)
• reciprocal increase in T and B cells in splenic red pulp (J:92670)
• reciprocal increase in T and B cells in splenic red pulp (J:92670)
• total lymphocyte numbers in peripheral lymph nodes are decreased to one half of wild-type (J:92670)
• total lymphocyte numbers in peripheral lymph nodes are decreased to one half of wild-type (J:92670)
• decrease in size and cellular density of B cell follicles and T cell zones (J:92670)
• decrease in size and cellular density of B cell follicles and T cell zones (J:92670)
• reduced numbers of CD11c+ (Itgax) dendritic cells in spleen (J:92670)
• following activation, dermal and splenic dendritic cells fail to migrate to draining lymph nodes and white pulp (J:92670)
• reduced numbers of CD11c+ (Itgax) dendritic cells in spleen (J:92670)
• following activation, dermal and splenic dendritic cells fail to migrate to draining lymph nodes and white pulp (J:92670)

cellular
• defective chemokine-triggered lymphocyte adhesion and migration (J:92670)
• defective chemokine-triggered lymphocyte adhesion and migration (J:92670)

endocrine/exocrine glands
• decrease in double positive CD4+ CD8+ cells (J:92670)
• increase in single positive CD4+ and CD8+ cells (J:92670)
• cellular migration out of thymus is 10% of wildtype (J:92670)
• decrease in double positive CD4+ CD8+ cells (J:92670)
• increase in single positive CD4+ and CD8+ cells (J:92670)
• cellular migration out of thymus is 10% of wildtype (J:92670)
• boundary of cortex and medulla ambiguous (J:92670)
• boundary of cortex and medulla ambiguous (J:92670)
• spotty appearance of medulla (J:92670)
• spotty appearance of medulla (J:92670)
• total thymocyte numbers decreased 50-60% in 7-9 week old mice (J:92670)
• total thymocyte numbers decreased 50-60% in 7-9 week old mice (J:92670)




Genotype
MGI:3054902
ht3
Allelic
Composition
Rassf5tm1Kina/Rassf5+
Genetic
Background
involves: C57BL/6 * CBA * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rassf5tm1Kina mutation (0 available); any Rassf5 mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• total lymphocyte numbers in peripheral lymph nodes are decreased to one third of wild-type (J:92670)
• total lymphocyte numbers in peripheral lymph nodes are decreased to one third of wild-type (J:92670)




Genotype
MGI:4939905
cx4
Allelic
Composition
Cdkn1btm2Kin/Cdkn1btm2Kin
Rassf5tm1Kina/Rassf5tm1Kina
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn1btm2Kin mutation (1 available); any Cdkn1b mutation (13 available)
Rassf5tm1Kina mutation (0 available); any Rassf5 mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• development of glomerulonephritis that is observed in single Rassf5 homozygotes is suppressed, in addition, CD138+B220+ plasma cells are reduced by 67%, CD44+CD62L- effector-memory T cells are reduced by 28%, and titers of antibodies to dsDNA are decreased by 58% compared to single Rassf5 homozygotes and deposition of IgG in the kidney is rarely detected compared to single Rassf5 homozygotes (J:168749)
• development of glomerulonephritis that is observed in single Rassf5 homozygotes is suppressed, in addition, CD138+B220+ plasma cells are reduced by 67%, CD44+CD62L- effector-memory T cells are reduced by 28%, and titers of antibodies to dsDNA are decreased by 58% compared to single Rassf5 homozygotes and deposition of IgG in the kidney is rarely detected compared to single Rassf5 homozygotes (J:168749)

homeostasis/metabolism
• incidence of proteinuria is reduced (22%) compared to single Rassf5 homozygotes (63%) (J:168749)
• incidence of proteinuria is reduced (22%) compared to single Rassf5 homozygotes (63%) (J:168749)

renal/urinary system
• incidence of proteinuria is reduced (22%) compared to single Rassf5 homozygotes (63%) (J:168749)
• incidence of proteinuria is reduced (22%) compared to single Rassf5 homozygotes (63%) (J:168749)

tumorigenesis
N
• mutants do not develop B cell lymphomas or other tumors (J:168749)
• mutants do not develop B cell lymphomas or other tumors (J:168749)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory